Analysis of glycaemic control and treatment satisfaction with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.

In unadjusted longitudinal analyses, the treatment group demonstrated a significant reduction in glucose standard deviation compared with the control group (mean difference −0.35 mmol/l; 95% CI −0.64, −0.06; p =0.018) and a trend toward improved TIR and coefficient of variation that did not reach statistical significance (Figs. 2 and 3 ).

also in 111,027 other papers